speb/financial-data huggingface dataset:
ILPT — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Real Estate | Industry: REIT - Industrial
Lynch category: Turnaround (confidence: High)
Market cap (USD): 203996341.26
Net income (USD): -226723000
P/B ratio: 0.1532918445472587
Pays dividend: no
Net asset value (USD): 790724000
Net cash (USD): -4297134000
Net cash to market cap %: -2106.4760149414456
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.2268571527501964 (Distress Zone)
Piotroski F-score: 3 (Weak)
ILPT — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Real Estate | Industry: REIT - Industrial
Lynch category: Turnaround (confidence: High)
Market cap (USD): 297328000.66
Net income (USD): -107989000
Revenue growth %: 12.67213017614279
Smoothed growth %: 12.67213017614279
P/B ratio: 0.25592475045598173
Pays dividend: no
Net asset value (USD): 669954000
Net cash (USD): -4289555000
Net cash to market cap %: -1442.7013232787262
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.2600839596852861 (Distress Zone)
Piotroski F-score: 6 (Neutral)
ILPT — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Real Estate | Industry: REIT - Industrial
Lynch category: Turnaround (confidence: High)
Market cap (USD): 233329148.5
Net income (USD): -95669000
Revenue growth %: 1.139621985741006
Smoothed growth %: 1.139621985741006
P/B ratio: 0.23117231083986406
Pays dividend: no
Net asset value (USD): 562019000
Net cash (USD): -4265295000
Net cash to market cap %: -1828.0163569019326
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.24036189468072133 (Distress Zone)
Piotroski F-score: 5 (Neutral)
ILPT — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Real Estate | Industry: REIT - Industrial
Lynch category: Turnaround (confidence: High)
Market cap (USD): 363326816.95
Net income (USD): -66187000
Revenue growth %: 1.4753957524156611
Smoothed growth %: 1.4753957524156611
P/B ratio: 0.4033836168726921
Pays dividend: no
Net asset value (USD): 489697000
Net cash (USD): -4194434000
Net cash to market cap %: -1154.4520812448661
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.24459646388004253 (Distress Zone)
Piotroski F-score: 6 (Neutral)
IMC.MC — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Industrials | Industry: Conglomerates
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
IMC.MC — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Industrials | Industry: Conglomerates
Lynch category: Speculative (confidence: Low)
Net income (USD): -73043617.0212766
Pays dividend: no
Net asset value (USD): 1534435106.382979
Net cash (USD): -1772292553.1914895
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
IMC.MC — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Industrials | Industry: Conglomerates
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 297974444.4444444
Revenue growth %: 15.13039557745765
Smoothed growth %: 15.13039557745765
Pays dividend: no
Net asset value (USD): 1938845555.5555556
Net cash (USD): -2012096666.6666665
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 7 (Neutral)
IMC.MC — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Industrials | Industry: Conglomerates
Lynch category: Asset Play (confidence: High)
Market cap (USD): 1439396224.0000002
Net income (USD): 184133333.33333334
EPS growth %: -38.204991479507925
Revenue growth %: 1.9890629880150854
Smoothed growth %: -38.204991479507925
P/E ratio: 7.817140970311368
P/B ratio: 0.4702372505717086
Pays dividend: no
Net asset value (USD): 2175852083.3333335
Net cash (USD): -1585251041.6666667
Net cash to market cap %: -110.13305545997225
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.5773458966943266 (Distress Zone)
Piotroski F-score: 7 (Neutral)
IMC.MC — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Industrials | Industry: Conglomerates
Lynch category: Asset Play (confidence: High)
Market cap (USD): 2064174381.1764708
Net income (USD): 454121176.47058827
EPS growth %: 146.62627252204288
Revenue growth %: 15.69995411534503
EPS 2-year CAGR %: 23.451499026446964
Smoothed growth %: 23.451499026446964
P/E ratio: 5.557275541795666
P/B ratio: 0.4998279422378027
PEG ratio: 0.23696888354678558
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 2855584705.882353
Net cash (USD): -1388267058.8235295
Net cash to market cap %: -67.2553187116047
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.0293987665599547 (Grey Zone)
Piotroski F-score: 7 (Neutral)
IMCR — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 1583445318.62
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
IMCR — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 1500534433
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
IMCR — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Low)
Market cap (USD): 1509181580.5800002
Net income (USD): 6523376.623376623
P/E ratio: 57.837438634610805
P/B ratio: 3.07036801789954
Pays dividend: no
Net asset value (USD): 491531168.83116883
Net cash (USD): 243507792.20779228
Net cash to market cap %: 16.135089066897354
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 1.0095179002782804 (Distress Zone)
Piotroski F-score: 3 (Weak)
IMCR — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 1596161712.12
Net income (USD): -14109589.04109589
P/B ratio: 2.999369466840334
Pays dividend: no
Net asset value (USD): 532165753.4246575
Net cash (USD): 258773972.6027398
Net cash to market cap %: 16.21226537623433
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 0.9392255410025678 (Distress Zone)
Piotroski F-score: 4 (Weak)
IMCR — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 1847946303.4199998
Net income (USD): -239189.1891891892
P/B ratio: 3.44832174511756
Pays dividend: no
Net asset value (USD): 535897297.2972973
Net cash (USD): 251914864.86486483
Net cash to market cap %: 13.632152860645638
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 1.145328123631879 (Distress Zone)
Piotroski F-score: 6 (Neutral)
IMCR — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 1765544073.54
Net income (USD): -40621621.62162162
P/B ratio: 3.4288437337962847
Pays dividend: no
Net asset value (USD): 514909459.4594595
Net cash (USD): 240428378.3783784
Net cash to market cap %: 13.617806656976173
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 0.9322205941102754 (Distress Zone)
Piotroski F-score: 2 (Weak)
IMCR — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1780295168
Net income (USD): 17067105.263157893
EPS growth %: 161.6299234049687
Revenue growth %: 15.125152839064471
Smoothed growth %: 161.6299234049687
P/E ratio: 22.464223318094213
P/B ratio: 2.960664720811434
PEG ratio: 0.13898554701290933
Pays dividend: no
Net asset value (USD): 517990789.4736842
Net cash (USD): 219044736.84210515
Net cash to market cap %: 12.303843810809306
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 1.1047533238564422 (Distress Zone)
Piotroski F-score: 7 (Neutral)
IME.AX — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category:  (confidence: Low)
Market cap (USD): 40599698.08695652
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
IME.AX — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 16906775.35135135
Net income (USD): -2053143.918918919
P/B ratio: 1.573653435380661
Pays dividend: no
Net asset value (USD): 5258289.864864865
Net cash (USD): -2145365.5405405406
Net cash to market cap %: -12.689383374157522
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.0466885400665817 (Grey Zone)
Piotroski F-score: 1 (Weak)
IME.AX — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 24962415.78082192
Net income (USD): -2871465.7534246575
Revenue growth %: 16.481077921115276
Smoothed growth %: 16.481077921115276
P/B ratio: 2.2801541778009793
Pays dividend: no
Net asset value (USD): 5071648.630136986
Net cash (USD): -2950576.027397261
Net cash to market cap %: -11.820074039725451
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.2077547451654826 (Grey Zone)
Piotroski F-score: 2 (Weak)
IME.AX — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Turnaround (confidence: High)
Market cap (USD): 12838739.47826087
Net income (USD): -1630713.664596273
Revenue growth %: 21.945090367993828
Smoothed growth %: 21.945090367993828
P/B ratio: 1.428113006691215
Pays dividend: no
Net asset value (USD): 3941704.347826087
Net cash (USD): -3267596.273291925
Net cash to market cap %: -25.451067675489213
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.7500871685149368 (Distress Zone)
Piotroski F-score: 4 (Weak)
IME.AX — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Turnaround (confidence: High)
Market cap (USD): 11134693.288590604
Net income (USD): -1934438.255033557
Revenue growth %: 18.350034108227646
Smoothed growth %: 18.350034108227646
P/B ratio: 1.3711245380439543
Pays dividend: no
Net asset value (USD): 6186018.120805369
Net cash (USD): -3060154.3624161077
Net cash to market cap %: -27.483059327298747
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.6905869451787432 (Distress Zone)
Piotroski F-score: 4 (Weak)
IMM.V — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 39585414.88
Net income (USD): -3345768
Pays dividend: no
Net asset value (USD): -474112.8
Net cash (USD): -533021.6
Net cash to market cap %: -1.3465100760363686
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -463.3879284323088 (Distress Zone)
Piotroski F-score: 1 (Weak)
IMM.V — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 7330632.385185185
Net income (USD): -588744.4444444444
Pays dividend: no
Net asset value (USD): -829565.9259259258
Net cash (USD): -872270.3703703703
Net cash to market cap %: -11.898978485583072
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -330.32358719219394 (Distress Zone)
Piotroski F-score: 3 (Weak)
IMM.V — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 3307604.8529411764
Net income (USD): -4001802.9629629627
Pays dividend: no
Net asset value (USD): -1038729.6296296295
Net cash (USD): -1094503.7037037036
Net cash to market cap %: -33.09052176321646
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -588.0649657873107 (Distress Zone)
Piotroski F-score: 3 (Weak)
IMM.V — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1572847.0629370632
Net income (USD): -605111.1888111888
Pays dividend: no
Net asset value (USD): -973451.7482517483
Net cash (USD): -980339.1608391609
Net cash to market cap %: -62.32895644720347
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2873.883638224963 (Distress Zone)
Piotroski F-score: 2 (Weak)
IMMO.BR — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Real Estate | Industry: Real Estate - Development
Lynch category: Asset Play (confidence: High)
Market cap (USD): 199226176.875
P/B ratio: 0.4779432831792727
Pays dividend: no
Net asset value (USD): 395638541.6666667
Net cash (USD): -1027672916.6666667
Net cash to market cap %: -515.8322730408349
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
IMMO.BR — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Real Estate | Industry: Real Estate - Development
Lynch category: Asset Play (confidence: High)
Market cap (USD): 226211641.41176474
P/B ratio: 0.4454057836996405
Pays dividend: no
Net asset value (USD): 484192941.1764706
Net cash (USD): -1060107058.8235294
Net cash to market cap %: -468.6350588358339
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
IMMO.BR — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Real Estate | Industry: Real Estate - Development
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 264715745.88235295
P/E ratio: 5.9201410757022295
P/B ratio: 0.5291474172264162
Pays dividend: no
Net asset value (USD): 508372941.1764706
Net cash (USD): -941054117.6470587
Net cash to market cap %: -355.4960867591493
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
IMMR — Peter Lynch category analysis (quarterly, as of 2024-10-31)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Market cap (USD): 259838548.2
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
IMMR — Peter Lynch category analysis (quarterly, as of 2025-01-31)
Sector: Technology | Industry: Software - Application
Lynch category: Turnaround (confidence: High)
Market cap (USD): 265465625.04
Net income (USD): 43230000
P/E ratio: 1.5351932977099236
P/B ratio: 0.46877786771159097
Pays dividend: no
Net asset value (USD): 216508000
Net cash (USD): -650339000
Net cash to market cap %: -244.98049414194693
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.9966443648957741 (Distress Zone)
Piotroski F-score: 2 (Weak)
IMMR — Peter Lynch category analysis (quarterly, as of 2025-04-30)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: High)
Market cap (USD): 231041154.96
Net income (USD): 6003000
P/E ratio: 9.62190383808096
P/B ratio: 0.4135371803220004
Pays dividend: no
Net asset value (USD): 137382000
Net cash (USD): -382181000
Net cash to market cap %: -165.4168496803813
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.0053788517907372 (Distress Zone)
Piotroski F-score: 6 (Neutral)
IMMR — Peter Lynch category analysis (quarterly, as of 2025-07-31)
Sector: Technology | Industry: Software - Application
Lynch category: Turnaround (confidence: High)
Market cap (USD): 224090060.04
Net income (USD): -930000
P/E ratio: 4.639257603875536
P/B ratio: 0.4103574718954009
Pays dividend: no
Net asset value (USD): 136039000
Net cash (USD): -548133000
Net cash to market cap %: -244.60388823232876
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.8111941573055051 (Distress Zone)
Piotroski F-score: 1 (Weak)
IMMR — Peter Lynch category analysis (quarterly, as of 2025-10-31)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: High)
Market cap (USD): 216476956.08
Net income (USD): 26882000
P/E ratio: 2.879257246525238
P/B ratio: 0.37723416289537565
Pays dividend: no
Net asset value (USD): 148117000
Net cash (USD): -616567000
Net cash to market cap %: -284.81876831829845
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.1657141964286213 (Distress Zone)
Piotroski F-score: 8 (Strong)
IMMR — Peter Lynch category analysis (quarterly, as of 2026-01-31)
Sector: Technology | Industry: Software - Application
Lynch category: Turnaround (confidence: High)
Market cap (USD): 215814944
Net income (USD): -10133000
EPS growth %: -123.43974092065694
Revenue growth %: 10.021177179573145
Smoothed growth %: -123.43974092065694
P/E ratio: 10.07180832554303
P/B ratio: 0.39107868171287646
Dividend yield: 0.05
Pays dividend: yes
Net asset value (USD): 137526000
Net cash (USD): -692797000
Net cash to market cap %: -321.01437794780327
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.9410251713987696 (Distress Zone)
Piotroski F-score: 2 (Weak)
IMNM — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 1655720760.28
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
IMNM — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 1202719184.28
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
IMNM — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 762175151.62
Net income (USD): -41640000
P/B ratio: 2.481636695102336
Pays dividend: no
Net asset value (USD): 307126000
Net cash (USD): 281756000
Net cash to market cap %: 36.967355784445196
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 11.182752670058823 (Safe Zone)
Piotroski F-score: 1 (Weak)
IMNM — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 1053228664.2
Net income (USD): -43397000
P/B ratio: 3.911422231217737
Pays dividend: no
Net asset value (USD): 269270000
Net cash (USD): 241016000
Net cash to market cap %: 22.88353974709455
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 21.07574055674928 (Safe Zone)
Piotroski F-score: 3 (Weak)
IMNM — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 1326162113.74
Net income (USD): -57457000
P/B ratio: 5.02488306541022
Pays dividend: no
Net asset value (USD): 263919000
Net cash (USD): 237181000
Net cash to market cap %: 17.884766691992862
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 19.695355412299094 (Safe Zone)
Piotroski F-score: 3 (Weak)
IMNM — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 2432618463.12
Net income (USD): -69900000
P/B ratio: 3.834862941846919
Pays dividend: no
Net asset value (USD): 634343000
Net cash (USD): 604637000
Net cash to market cap %: 24.855397965882066
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 29.11919493045895 (Safe Zone)
Piotroski F-score: 5 (Neutral)
IMNM — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 2515291136
Net income (USD): -53839000
Revenue growth %: -100
Smoothed growth %: -100
P/B ratio: 4.207312755492742
Pays dividend: no
Net asset value (USD): 588686000
Net cash (USD): 551587000
Net cash to market cap %: 21.92935012990878
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 47.53243925511544 (Safe Zone)
Piotroski F-score: 3 (Weak)
INAB — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 77676262.2
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
INAB — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 73936294.02
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
INAB — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 47756516.760000005
Net income (USD): -5550000
P/B ratio: 3.4414150580096567
Pays dividend: no
Net asset value (USD): 13877000
Net cash (USD): 5896000
Net cash to market cap %: 12.345959043935933
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -4.531214020402864 (Distress Zone)
Piotroski F-score: 2 (Weak)
INAB — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 20042393.58
Net income (USD): -5094000
P/B ratio: 1.3152039884506856
Pays dividend: no
Net asset value (USD): 15239000
Net cash (USD): 9094000
Net cash to market cap %: 45.37382206222497
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -6.807243809796462 (Distress Zone)
Piotroski F-score: 5 (Neutral)
INAB — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 20809566.54
Net income (USD): -3854000
P/B ratio: 1.5777971445901886
Pays dividend: no
Net asset value (USD): 13189000
Net cash (USD): 7110000
Net cash to market cap %: 34.16697789611912
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -7.939626988352858 (Distress Zone)
Piotroski F-score: 3 (Weak)
INAB — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 22439809.08
Net income (USD): -4942000
P/B ratio: 0.8142756760287393
Pays dividend: no
Net asset value (USD): 27558000
Net cash (USD): 22368000
Net cash to market cap %: 99.67999246453483
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -2.8645524637563944 (Distress Zone)
Piotroski F-score: 5 (Neutral)
INAB — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 11507595
Net income (USD): -5090000
P/B ratio: 0.6230060032483209
Pays dividend: no
Net asset value (USD): 22781000
Net cash (USD): 18457000
Net cash to market cap %: 160.3897252206043
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -5.5351867818465985 (Distress Zone)
Piotroski F-score: 3 (Weak)
INBS — Peter Lynch category analysis (annual, as of 2021-06-30)
Sector: Healthcare | Industry: Medical Devices
Lynch category:  (confidence: Medium)
Market cap (USD): 22617295776
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
INBS — Peter Lynch category analysis (annual, as of 2022-06-30)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 3800164924.7999997
Net income (USD): -8306051
P/B ratio: 580.5526842903608
Pays dividend: no
Net asset value (USD): 6624922
Net cash (USD): 2431899
Net cash to market cap %: 0.06399456466032166
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 387.5291135836756 (Safe Zone)
Piotroski F-score: 2 (Weak)
INBS — Peter Lynch category analysis (annual, as of 2023-06-30)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Speculative (confidence: Low)
Market cap (USD): 797919825.6
Net income (USD): -10631720
P/B ratio: 216.41449916707307
Pays dividend: no
Net asset value (USD): -1456417
Net cash (USD): -5130370
Net cash to market cap %: -0.6429681072458867
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 63.34840277757378 (Safe Zone)
Piotroski F-score: 3 (Weak)
INBS — Peter Lynch category analysis (annual, as of 2024-06-30)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Turnaround (confidence: High)
Market cap (USD): 45923443.199999996
Net income (USD): -10156759
Revenue growth %: 147.58137662387261
Smoothed growth %: 147.58137662387261
P/B ratio: 5.611923661564297
Pays dividend: no
Net asset value (USD): 3957324
Net cash (USD): 708426
Net cash to market cap %: 1.542623877122524
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2.3240683087483145 (Distress Zone)
Piotroski F-score: 7 (Neutral)
INBS — Peter Lynch category analysis (annual, as of 2025-06-30)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Turnaround (confidence: High)
Market cap (USD): 41139751.199999996
Net income (USD): -10568733
Revenue growth %: -1.9040221660843097
Smoothed growth %: -1.9040221660843097
P/B ratio: 14.620584372014738
Pays dividend: no
Net asset value (USD): -794183
Net cash (USD): -4416053
Net cash to market cap %: -10.734272500899326
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -10.047372888410116 (Distress Zone)
Piotroski F-score: 4 (Weak)
INCY — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Medium)
Market cap (USD): 14664010177.000002
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
INCY — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 16046502689.599998
Net income (USD): 340660000
P/E ratio: 47.10415866142194
P/B ratio: 3.6718685897569374
Pays dividend: no
Net asset value (USD): 4085307000
Net cash (USD): 1768100000
Net cash to market cap %: 11.018600340533608
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 7.959514758523866 (Safe Zone)
Piotroski F-score: 4 (Weak)
INCY — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 12544321512.45
Net income (USD): 597599000
EPS growth %: 75.42388305054894
Revenue growth %: 8.867345090120146
Smoothed growth %: 75.42388305054894
P/E ratio: 20.991202315348588
P/B ratio: 2.4170935450284854
PEG ratio: 0.2783097537060022
Pays dividend: no
Net asset value (USD): 4910699000
Net cash (USD): 2063773000
Net cash to market cap %: 16.451850328865888
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 6.226329042019451 (Safe Zone)
Piotroski F-score: 6 (Neutral)
INCY — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 13798953445.849998
Net income (USD): 32615000
EPS growth %: -94.54232687805703
Revenue growth %: 14.762440913625726
EPS 2-year CAGR %: -69.05801862401427
Smoothed growth %: -94.54232687805703
P/E ratio: 423.08610902498845
P/B ratio: 4.002448479316794
Pays dividend: no
Net asset value (USD): 3178232000
Net cash (USD): 161398000
Net cash to market cap %: 1.1696394268837835
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 5.063104972043497 (Safe Zone)
Piotroski F-score: 5 (Neutral)
INCY — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 19732483449.35
Net income (USD): 1286650000
EPS growth %: 3844.9639736317645
Revenue growth %: 21.220913714153273
EPS 2-year CAGR %: 46.73215000784061
Smoothed growth %: 46.73215000784061
P/E ratio: 15.336325690242102
P/B ratio: 3.8185907031147495
PEG ratio: 0.3281750505309302
Pays dividend: no
Net asset value (USD): 4917347000
Net cash (USD): 1790109000
Net cash to market cap %: 9.071889022965163
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 8.636306293041915 (Safe Zone)
Piotroski F-score: 8 (Strong)
INDBANK.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Financial Services | Industry: Capital Markets
Lynch category:  (confidence: Low)
Market cap (USD): 24526747.658862878
P/B ratio: 2.295478880576659
Pays dividend: no
Net asset value (USD): 10670365.504061157
Net cash (USD): 5193275.2030578125
Net cash to market cap %: 21.173925199092565
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
INDBANK.NS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 23934949.457978785
Net income (USD): 136834.1298519641
P/E ratio: 43.72986016696482
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
INDBANK.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 14563134.368070954
Net income (USD): 133025.48515314472
P/E ratio: 27.36906832421104
P/B ratio: 1.3592006627752562
Pays dividend: no
Net asset value (USD): 10703542.202478372
Net cash (USD): 6479962.590600887
Net cash to market cap %: 44.49565887964288
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.468763962749832 (Safe Zone)
Piotroski F-score: 2 (Weak)
INDBANK.NS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 18091931.757547393
Net income (USD): 250280.83313831035
P/E ratio: 34.78278188540122
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
INDBANK.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 17208478.80138131
Net income (USD): 213501.16965578703
P/E ratio: 23.45624673393485
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
INDBANK.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 15411971.852479864
Net income (USD): 128624.4171259008
EPS growth %: -5.999755130496383
Revenue growth %: -28.596782588631747
Smoothed growth %: -5.999755130496383
P/E ratio: 0.19505530462283074
P/B ratio: 1.306999394857759
Pays dividend: no
Net asset value (USD): 10454281.475201357
Net cash (USD): 6604239.0843577795
Net cash to market cap %: 42.8513570331698
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.636227492199379 (Safe Zone)
Piotroski F-score: 2 (Weak)
INDBANK.NS — Peter Lynch category analysis (quarterly, as of 2026-06-30)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 15548052.916974364
Net income (USD): 250585.50480008437
EPS growth %: 88.37405818261023
Revenue growth %: 59.07951661070436
Smoothed growth %: 88.37405818261023
P/E ratio: 0.21335839671107104
PEG ratio: 0.0024142650128185983
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
INDI — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Technology | Industry: Semiconductors
Lynch category:  (confidence: Medium)
Market cap (USD): 2533350206.09
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
INDI — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Technology | Industry: Semiconductors
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 1231812485.53
Net income (USD): -43400000
P/B ratio: 3.918826226823868
Pays dividend: no
Net asset value (USD): 113232000
Net cash (USD): 32610000
Net cash to market cap %: 2.647318515039179
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 2.1399183825828803 (Grey Zone)
Piotroski F-score: 1 (Weak)
INDI — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Technology | Industry: Semiconductors
Lynch category: Speculative (confidence: Low)
Market cap (USD): 1713550473.01
Net income (USD): -117625000
Revenue growth %: 101.42151863317599
Smoothed growth %: 101.42151863317599
P/B ratio: 3.592160731638803
Pays dividend: no
Net asset value (USD): -57081000
Net cash (USD): -190173000
Net cash to market cap %: -11.098184908784429
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 2.3112063019652522 (Grey Zone)
Piotroski F-score: 4 (Weak)
INDI — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Technology | Industry: Semiconductors
Lynch category: Turnaround (confidence: High)
Market cap (USD): 855718793.55
Net income (USD): -132603000
Revenue growth %: -2.9067657246302128
Smoothed growth %: -2.9067657246302128
P/B ratio: 1.9212581945239615
Pays dividend: no
Net asset value (USD): -57426000
Net cash (USD): -221743000
Net cash to market cap %: -25.91306883422369
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 0.3624242034252033 (Distress Zone)
Piotroski F-score: 5 (Neutral)
INDI — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Technology | Industry: Semiconductors
Lynch category: Turnaround (confidence: High)
Market cap (USD): 745848726.2299999
Net income (USD): -143066000
Revenue growth %: 0.32859213040307916
Smoothed growth %: 0.32859213040307916
P/B ratio: 1.9422486380148587
Pays dividend: no
Net asset value (USD): -130521000
Net cash (USD): -311317000
Net cash to market cap %: -41.739965364504506
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: -0.09366377504082168 (Distress Zone)
Piotroski F-score: 3 (Weak)
INDP — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Medium)
Market cap (USD): 4626173489.28
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
INDP — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Medium)
Market cap (USD): 3141853999.9199996
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
INDP — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 2051931789.6000001
Net income (USD): -4532430
P/B ratio: 732.9031930567616
Pays dividend: no
Net asset value (USD): 2799731
Net cash (USD): 1279130
Net cash to market cap %: 0.06233784214870764
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 452.2911724106843 (Safe Zone)
Piotroski F-score: 1 (Weak)
INDP — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 1403041671.72
Net income (USD): -5228919
Pays dividend: no
Net asset value (USD): -1673356
Net cash (USD): -2354862
Net cash to market cap %: -0.16783977607116657
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 82.00305829990111 (Safe Zone)
Piotroski F-score: 3 (Weak)
INDP — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 382405469.88
Net income (USD): -2975117
P/B ratio: 83.02825371108622
Pays dividend: no
Net asset value (USD): 4605727
Net cash (USD): 3591314
Net cash to market cap %: 0.9391377171270499
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 87.17272855225046 (Safe Zone)
Piotroski F-score: 5 (Neutral)
INDP — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 387735162.84000003
Net income (USD): -8112450
P/B ratio: 123.02831071144023
Pays dividend: no
Net asset value (USD): 3151593
Net cash (USD): 2349053
Net cash to market cap %: 0.6058395588355093
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 23.067010982292047 (Safe Zone)
Piotroski F-score: 3 (Weak)
INDP — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 347762432
Net income (USD): -2541070
P/B ratio: 194.33398993634688
Pays dividend: no
Net asset value (USD): 1247857
Net cash (USD): 564636
Net cash to market cap %: 0.1623625636480481
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 167.246365798407 (Safe Zone)
Piotroski F-score: 2 (Weak)
INDRAMEDCO.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category:  (confidence: Low)
Market cap (USD): 65668961.6246868
Pays dividend: no
Net cash (USD): 5332981.669523935
Net cash to market cap %: 8.121008064667064
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
INDRAMEDCO.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 82840680.51157126
Net income (USD): 10493300.852618758
P/E ratio: 7.8946255020313405
P/B ratio: 1.792388949795757
Pays dividend: no
Net asset value (USD): 46101096.22411694
Net cash (USD): -5200974.421437271
Net cash to market cap %: -6.278285486453475
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.763918021985781 (Safe Zone)
Piotroski F-score: 4 (Weak)
INDRAMEDCO.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 184907608.20537427
Net income (USD): 14865091.73761842
EPS growth %: 41.662685044512166
Revenue growth %: 11.313565613825714
Smoothed growth %: 41.662685044512166
P/E ratio: 12.439049248343142
P/B ratio: 3.2274458825029635
PEG ratio: 0.2985657125807743
Pays dividend: no
Net asset value (USD): 57166326.897709556
Net cash (USD): -2057800.6955270395
Net cash to market cap %: -1.112880489612666
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 7.107012788446308 (Safe Zone)
Piotroski F-score: 7 (Neutral)
INDRAMEDCO.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 409196006.18508583
Net income (USD): 18820434.88426467
EPS growth %: 26.60826597280016
Revenue growth %: 9.817505018316728
EPS 2-year CAGR %: 33.92410875767147
Smoothed growth %: 33.92410875767147
P/E ratio: 21.74211216166982
P/B ratio: 5.866230872338982
PEG ratio: 0.6409044469518492
Pays dividend: no
Net asset value (USD): 69685527.23871872
Net cash (USD): 8530512.041150335
Net cash to market cap %: 2.084700708758103
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 10.96097339370939 (Safe Zone)
Piotroski F-score: 7 (Neutral)
INDRAMEDCO.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Stalwart (confidence: Medium)
Market cap (USD): 354217639.33870286
Net income (USD): 19459516.744383212
EPS growth %: 3.395680620817447
Revenue growth %: -0.9158994053992983
EPS 2-year CAGR %: 14.414806002016878
Smoothed growth %: 14.414806002016878
P/E ratio: 0.19623233908948196
P/B ratio: 4.590026756891826
PEG ratio: 0.013613248701510495
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 78426239.93217465
Net cash (USD): 2461848.2407799885
Net cash to market cap %: 0.6950100636930646
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 10.527854581024398 (Safe Zone)
Piotroski F-score: 6 (Neutral)
INDUSTOWER.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Communication Services | Industry: Telecom Services
Lynch category:  (confidence: Medium)
Market cap (USD): 12365370969.424273
P/B ratio: 3.645326061524431
Pays dividend: no
Net asset value (USD): 3386956521.7391305
Net cash (USD): -3012052078.3564262
Net cash to market cap %: -24.358768417092353
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
INDUSTOWER.NS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Communication Services | Industry: Telecom Services
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 10506952733.502739
Net income (USD): 466627812.09931225
P/E ratio: 5.629193364103717
P/B ratio: 2.7855802214121486
Pays dividend: no
Net asset value (USD): 3767035785.0565333
Net cash (USD): -2775440027.9752884
Net cash to market cap %: -26.41527090081455
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.339275921635275 (Grey Zone)
Piotroski F-score: 6 (Neutral)
INDUSTOWER.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Communication Services | Industry: Telecom Services
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 10288394812.430857
Net income (USD): 207984568.62286648
P/E ratio: 12.366776632220441
P/B ratio: 2.7080471663297327
Pays dividend: no
Net asset value (USD): 3794750993.687164
Net cash (USD): -3219090483.984101
Net cash to market cap %: -31.288559028612166
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.6453658599461107 (Grey Zone)
Piotroski F-score: 5 (Neutral)
INDUSTOWER.NS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Communication Services | Industry: Telecom Services
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 12994624695.347532
Net income (USD): 203229581.0905687
P/E ratio: 14.80292041236395
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
INDUSTOWER.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Communication Services | Industry: Telecom Services
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 12301695782.83391
Net income (USD): 197827782.10983625
P/E ratio: 11.436312913268358
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 2 (Weak)
INDUSTOWER.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Communication Services | Industry: Telecom Services
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 11028350296.227215
Net income (USD): 190006358.62653667
EPS growth %: -59.280961464402026
Revenue growth %: -2.4134419739536543
Smoothed growth %: -59.280961464402026
P/E ratio: 0.16291712472294545
P/B ratio: 2.769170663562593
Pays dividend: no
Net asset value (USD): 4196407376.0067825
Net cash (USD): -2303094531.5811787
Net cash to market cap %: -20.88340023411357
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.316250952210766 (Grey Zone)
Piotroski F-score: 3 (Weak)
INFOMEDIA.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Financial Services | Industry: Shell Companies
Lynch category:  (confidence: Low)
Market cap (USD): 5204078.033444816
Pays dividend: no
Net asset value (USD): -6736383.182035356
Net cash (USD): -7814930.721452461
Net cash to market cap %: -150.16936085947586
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
INFOMEDIA.NS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Financial Services | Industry: Shell Companies
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 4159931.960834596
Net income (USD): -103217.15817694369
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
INFOMEDIA.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Financial Services | Industry: Shell Companies
Lynch category: Turnaround (confidence: High)
Market cap (USD): 3497014.900688528
Net income (USD): -106207.62216506897
Pays dividend: no
Net asset value (USD): -6805903.6707972875
Net cash (USD): -7923906.94411971
Net cash to market cap %: -226.59059709924514
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -15.773665135518595 (Distress Zone)
Piotroski F-score: 1 (Weak)
INFOMEDIA.NS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Financial Services | Industry: Shell Companies
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 4587134.136672127
Net income (USD): -120301.89562368361
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
INFOMEDIA.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Financial Services | Industry: Shell Companies
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 3550551.3222680185
Net income (USD): -101882.58883814192
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)